Characteristics of the 15 Autograft Recipients
| Median age in yrs (range) | 44 (18-56) |
| Sex (male/female) | 7/8 |
| Underlying disease | |
| Multiple myeloma | 5 |
| Hodgkin's lymphoma | 4 |
| Non-Hodgkin's lymphoma | 3 |
| Other* | 3 |
| Type of transplantation | |
| PBSC | 13 |
| BM | 2 |
| Pretransplant conditioning regimen | |
| BCNU/VP-16/cytarabine/melphalan (BEAM) | 6 |
| Busulfan/cyclophosphamide | 5 |
| Other† | 4 |
| Patients alive at 3 mos after transplantation | 15 |
| Median age in yrs (range) | 44 (18-56) |
| Sex (male/female) | 7/8 |
| Underlying disease | |
| Multiple myeloma | 5 |
| Hodgkin's lymphoma | 4 |
| Non-Hodgkin's lymphoma | 3 |
| Other* | 3 |
| Type of transplantation | |
| PBSC | 13 |
| BM | 2 |
| Pretransplant conditioning regimen | |
| BCNU/VP-16/cytarabine/melphalan (BEAM) | 6 |
| Busulfan/cyclophosphamide | 5 |
| Other† | 4 |
| Patients alive at 3 mos after transplantation | 15 |